Skip to main content
Fig. 3 | BMC Neurology

Fig. 3

From: Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges

Fig. 3

During the 2nd cycle of maintenance therapy following induction therapy with temozolomide, the patient experienced constitutional symptoms and cytopenia. Computed tomography showed systemic lymphadenopathy (A; arrowhead) and splenomegaly (B; asterisk). Positron emission tomography showed marked fluorodeoxyglucose-avid lymph nodes in the neck, axillae, mediastinum and para-aortic region (C)

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us